Sequencing firm Lexogen has appointed Stéphane Barges as CEO, effective Sept. 1.
Barges comes to Lexogen from Qiagen, where he was VP of molecular diagnostics. He has 20 years of experience in the life science and clinical diagnostics industry, including management positions at Life Technologies, Bio-Rad Laboratories, and Tecan. He holds a doctorate in genetics and molecular biology from the University of Geneva and an MBA from HEC Geneva.
Barges will succeed Lexogen founder Alexander Seitz, who will take on the role of chief innnovation officer.